Acute kidney injury in a child treated with cisplatin and amphotericin B.
Autor: | Skajaa T; Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N, 8200, Denmark. torska@rm.dk., Faerch M; Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N, 8200, Denmark., Hasle H; Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N, 8200, Denmark. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Oct; Vol. 94 (4), pp. 623-626. Date of Electronic Publication: 2024 Aug 07. |
DOI: | 10.1007/s00280-024-04705-0 |
Abstrakt: | Cisplatin and amphotericin B are both known to be potentially nephrotoxic. We describe acute kidney injury due to the combination of Liposomal amphotericin B and cisplatin in an adolescent with osteosarcoma. Acute kidney injury (peak creatinine 431 µmol/L) consistent with drug-induced acute tubulointerstitial nephritis was observed a few days after concomitant administration of cisplatin and amphotericin B. Kidney function nearly normalised during follow-up. The timing of the concomitant administration of amphotericin B and cisplatin led us to presume that the combination was the cause of renal failure, and we conclude that concurrent administration of cisplatin and amphotericin B should be avoided. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |